1. Home
  2. VFF vs LXEO Comparison

VFF vs LXEO Comparison

Compare VFF & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$2.73

Market Cap

357.1M

Sector

N/A

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

BUY

Current Price

$3.37

Market Cap

348.7M

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
VFF
LXEO
Founded
1989
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
357.1M
348.7M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
VFF
LXEO
Price
$2.73
$3.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$5.83
★ $20.30
AVG Volume (30 Days)
701.6K
★ 1.6M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 184.38
39.81
EPS
★ 0.08
N/A
Revenue
★ $215,937,000.00
$654,000.00
Revenue This Year
$12.34
N/A
Revenue Next Year
$20.22
N/A
P/E Ratio
$34.75
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.81
$2.98
52 Week High
$4.99
$10.99

Technical Indicators

Market Signals
Indicator
VFF
LXEO
Relative Strength Index (RSI) 43.00 34.49
Support Level $2.49 $2.98
Resistance Level $3.18 $5.38
Average True Range (ATR) 0.11 0.29
MACD -0.05 -0.02
Stochastic Oscillator 6.98 26.79

Price Performance

Historical Comparison
VFF
LXEO

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: